US Equity
SVRA
— SAVARA INC.Savara Inc. is a clinical-stage biopharmaceutical company that develops treatments for rare respiratory diseases, including pulmonary alveolar proteinosis.
💰 Market cap: $1.11B📍 1717 Langhorne Newtown Road, Suite 300, LANGHORNE, PA, 19047 US🏷️ Biotechnology & Medical Research💵 Previous close: $5.51🔢 9,756 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $5.51 |
| 2026-07-23 | $5.75 |
| 2026-07-22 | $5.65 |
| 2026-07-21 | $5.84 |
| 2026-07-20 | $5.49 |
| 2026-07-17 | $5.52 |
| 2026-07-16 | $5.52 |
| 2026-07-15 | $5.81 |
| 2026-07-14 | $5.69 |
| 2026-07-13 | $5.74 |
| 2026-07-10 | $6.03 |
| 2026-07-09 | $6.29 |
| 2026-07-08 | $6.38 |
| 2026-07-07 | $6.21 |
| 2026-07-06 | $6.20 |
| 2026-07-02 | $6.22 |
| 2026-07-01 | $6.06 |
| 2026-06-30 | $6.16 |
| 2026-06-29 | $6.03 |
| 2026-06-26 | $5.90 |
| 2026-06-25 | $6.03 |
| 2026-06-24 | $5.83 |
| 2026-06-23 | $5.78 |
| 2026-06-22 | $5.69 |
| 2026-06-18 | $5.50 |
| 2026-06-17 | $5.38 |
| 2026-06-16 | $5.30 |
| 2026-06-15 | $5.33 |
| 2026-06-12 | $5.26 |
| 2026-06-11 | $5.27 |
| 2026-06-10 | $5.09 |
| 2026-06-09 | $4.93 |
| 2026-06-08 | $5.06 |
| 2026-06-05 | $5.09 |
| 2026-06-04 | $5.30 |
| 2026-06-03 | $5.25 |
| 2026-06-02 | $5.25 |
| 2026-06-01 | $5.15 |
| 2026-05-29 | $5.20 |
| 2026-05-28 | $5.09 |
| 2026-05-27 | $5.21 |
| 2026-05-26 | $5.14 |
| 2026-05-22 | $5.02 |
| 2026-05-21 | $5.06 |
| 2026-05-20 | $5.08 |
| 2026-05-19 | $4.72 |
| 2026-05-18 | $4.91 |
| 2026-05-15 | $5.03 |
| 2026-05-14 | $5.27 |
| 2026-05-13 | $5.27 |
| 2026-05-12 | $5.08 |
| 2026-05-11 | $5.12 |
| 2026-05-08 | $5.23 |
| 2026-05-07 | $5.16 |
| 2026-05-06 | $5.27 |
| 2026-05-05 | $5.25 |
| 2026-05-04 | $5.30 |
| 2026-05-01 | $5.12 |
| 2026-04-30 | $5.24 |
| 2026-04-29 | $4.85 |
| 2026-04-28 | $5.02 |